Safety Shot Quote - SHOTW | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Safety Shot Inc (SHOTW) Share Price

Safety Shot Inc (SHOTW)

0.11

-0.04

( -26.67% )

Updated: 10:41:32

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

0.11

Bid

0.112

Ask

0.16

Volume

3,075

0.1001 Day's Range 0.1499

0.1001 52 Week Range 3.00

Previous Close

0.15

Open

0.11

Last Trade

Last Trade Time

13:00:20

Average Volume (3m)

2,844

Financial Volume

US$ 357

VWAP

0.116

Form 8-K - Current report

Safety Shot Expands Retail Footprint with Major Grocery Chain in US Southwest

Company's Rapid Alcohol-Reducing Beverage, Sure Shot, to be Sold in 192 Stores Across Nevada, Arizona, and California JUPITER, Fla., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq:...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Sure Shot, the Revolutionary Alcohol-Reducing Beverage, Launches in USA Today’s Best Grocery Store in America

The Company's new 4 oz. format is designed to enhance social experiences while promoting responsible drinking. JUPITER, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT...

Form 8-K - Current report

Form 8-K - Current report

Safety Shot Reports Transformative Third Quarter 2024: Rebranding, Strategic Partnerships, and Expanded Distribution Drive Growth

Jupiter, FL, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (The “Company” or “Safety Shot”), a leading innovator in the functional beverage industry, today announced key...

Form 8-K - Current report

Safety Shot Expands Reach in Metro Chicago with New Distribution Agreement

The Company's innovative alcohol-reducing beverage, Sure Shot, will be available in 450+ stores across the Chicago area. JUPITER, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc...

Form EFFECT - Notice of Effectiveness

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.03	-21.4285714286	0.14	0.17	0.1001	3108	0.1457882	CS
4	-0.080653	-42.3035567235	0.190653	0.2162	0.1001	2667	0.133675	CS
12	-0.11	-50	0.22	0.5	0.1001	2844	0.21173932	CS
26	-0.22	-66.6666666667	0.33	0.5	0.1001	2762	0.21411046	CS
52	-1.78	-94.1798941799	1.89	3	0.1001	6120	1.0891754	CS
156	-0.31	-73.8095238095	0.42	3	0.0512	6260	1.04199186	CS
260	-0.31	-73.8095238095	0.42	3	0.0512	6260	1.04199186	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CRNCCerence Inc	US$ 6.1727 (118.89%)	64.35M
WORXSCWorx Corporation	US$ 2.01 (105.10%)	130.13M
SPAISafe Pro Group Inc	US$ 4.589 (43.41%)	41.46M
INVZWInnoviz Technologies Ltd	US$ 0.07 (37.86%)	6.41k
ARQQArqit Quantum Inc	US$ 9.92 (35.15%)	635.49k
SKKSKK Holdings Limited	US$ 0.80 (-82.46%)	23.72M
WCTWellchange Holdings Company Limited	US$ 1.00 (-69.88%)	1.78M
TMTCTMT Acquisition Corporation	US$ 2.375 (-63.12%)	316.51k
GLXGGalaxy Payroll Group Ltd	US$ 1.7062 (-56.36%)	2.18M
TMTCUTMT Acquisition Corporation	US$ 3.20 (-52.10%)	11.54k
CDTConduit Pharmaceuticals Inc	US$ 0.1109 (20.15%)	554.38M
NVDANVIDIA Corporation	US$ 147.13 (0.85%)	315.15M
ELABElevai Labs Inc	US$ 0.0204 (-4.67%)	206.05M
AKTSAkoustis Technologies Inc	US$ 0.101 (15.96%)	199.04M
WORXSCWorx Corporation	US$ 2.01 (105.10%)	130.13M

manibiotech

manibiotech 5 minutes ago

However the data of current trial submitted for approval is not "in vitro"

payupdeadbeat

payupdeadbeat 5 minutes ago

It is clear that the "investment of a lifetime* message is not getting out. I hope the longs are not being hornscwaggled.

Craig305

Craig305 5 minutes ago

This is the highest day volume since June 2022.

Serpico2005

Serpico2005 5 minutes ago

HUGE revenue pouring in here, we won't be denied, won't be able the hold it down much longer.

delerious1

delerious1 5 minutes ago

Milling results soon yet some say that this stock is garbage etc have been here as long as me or longer so that would mean plenty of time to see the patterns and make some really good money....but I bet that they haven't....so it is a bit of a conundrum....why wouldn't they when obviously given the

ExtremelyBullishZig

ExtremelyBullishZig 6 minutes ago

No...all biotechs are up based on gene editing company success it move the index

richme

richme 6 minutes ago

Need to Curb Your Enthusiasm just because the share price jumped all the way to $0.0166 share price,
-$0.0015 day change. Isn't that great? We will be heading to Mars soon....no less in Elon Musk's rocket ship or to hell in ________ (add your own).

Quintessence

Quintessence 6 minutes ago

PDYNW - Nice move today! I will consider buying dips.

JRoon71

JRoon71 6 minutes ago

TC, I get that. I just meant that in looking at what Italy pays for other drugs, what Amarin wants for Vazkepa is substantially more than MOST drugs on the list.

I'm not talking about the cost to patients, but the cost to the government.

If Vazkepa cost $15 to sell to

dennisdave

dennisdave 7 minutes ago

BTW, the three companies with approved PD1 inhibitors, which is what the U.S. patent office tried to narrow the combo patent to, are:

Merck = Keytruda

Opdivo = Bristol

Libtayo = Regeneron.
Thanks very helpful.

attilathehunt

attilathehunt 7 minutes ago

1 buy of 20k will work the same as 2 buys of 10k on squeeze day, no?

NO!!!!!

On squeeze day your first buy order will be much much lower than all subsequent ones...

For example, on Squeeze day (approval) if your first early open trade gets executed at 1.0

bgATL

bgATL 7 minutes ago

Gaetz is out, my opinion has been he was never really going to be in the position, as it was cover to let him resign from the House before the severe reprimands which could have ruined his chances of a future career. Trump also could now argue he tried to put a pot friendly guy in the office and it

Pic 7 minutes ago

I wonder if .0011 is a good entry? Fishing time. 🎣

konshe

konshe 7 minutes ago

Strong buy at ask 0.0002, paint sell at bid 0.0001. 0.0002 2mm shares will be gone soon.

al44

al44 7 minutes ago

The world will become safer when the ‘adults in the room’ are… gone

By Jack Hellner

When Biden and his team of incompetents took over, the media cheered that finally the adults were back in the room; well thankfully, the “children” will be back soon and the U.S.

Real McCoy

Real McCoy 7 minutes ago

I think they think that announced participation in a hot industry segment should entitle them to valuation levels of those hot industry segment leaders. Despite ALWAYS having virtually no revenue.

KRISGO

KRISGO 7 minutes ago

Hello Dcaf7, based on the full abstract being released on Nov 25th, can the experts evaluate whether same-day dosing is effective and works better?

PennyMillions852

PennyMillions852 7 minutes ago

BID building here but...you KNOW what will come next......this is the type of chit that needs to stop for us to move up above .0003!

Hitman970

Hitman970 7 minutes ago

Why hasn't this historic moment made any mainstream press?
x / twitter and company generate PRs mean nothing.
You are repeating yourself over and over. Do you know Vic? You called him "benign" a while back.

CrashOverride

CrashOverride 8 minutes ago

If it was DCVax the 2016 paper would cite Liau or Prins as they are the leaders in the field of Dendritic-cell-based vaccines.

They had several papers published before 2016.

It doesn't so it isn't DCVax.

biotechinvestor1

biotechinvestor1 8 minutes ago

From another poster: “Evotec has already said no thanks. Wall Street said no thanks. When Halozyme management says ok forget about it, we go up $10. We are waiting Ms Helen.”

BamaBreeze

BamaBreeze 8 minutes ago

Can you bring in the update your referencing(please).

redspinelpinktopaz

redspinelpinktopaz 8 minutes ago

No. It seems all right to me.

glenn1919

glenn1919 8 minutes ago

TRNR....CISO....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

WinstonCup

WinstonCup 8 minutes ago

Sometimes you make no sense.

MilkyWay Token by SpaceSwap v2

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions